Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04736693 · ClinicalTrials.gov registry record
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 18,028
- Enrollment target
NCT04736693: Completed study, sponsored by Brigham and Women's Hospital.
NCT04736693 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 18,028 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04736693 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 18,028 participants
- Enrollment target
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Primary Outcome
Please refer to attached protocol for full definition due to size limitations
Interventions
- DRUG Zoledronic Acid
- DRUG Raloxifene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,028 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2021-02-18 |
What the finished NCT04736693 record still lists
NCT04736693 is an observational study that tracks outcomes without assigning an intervention. Its 18,028 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Zoledronic Acid is the first listed.
NCT04736693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04736693 about?
NCT04736693 is a clinical study titled "Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT04736693?
This trial is currently completed. The enrollment target is 18,028 participants. The study started on 2020-09-22. Estimated completion is 2021-02-18.
What interventions are being tested in trial NCT04736693?
The interventions under investigation include: Zoledronic Acid (DRUG), Raloxifene (DRUG).
Who is sponsoring clinical trial NCT04736693?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
- NCT05513833 · 18,000 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
- NCT06802224 · 18,000 participants · Phase 4
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
- NCT07108660 · 17,800 participants · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI